This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Health Law Diagnosed: The Summer / Fall 2025 PBM Policy And Legislative Update (Podcast)

In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate David Gilboa for an overview of the Summer / Fall 2025 PBM Policy and Legislative Update...

United States Healthcare

M

Mintz

Navigating Co-Parenting In Same-Sex Divorces

Navigating divorce as same-sex parents in Houston brings unique legal and emotional challenges, especially when co-parenting and your child's future are at stake.

United States Healthcare

DS

Diggs & Sadler

Complete Response Letters In Transition: Navigating FDA's Transparency Policy And Manufacturing-Related Actions, And How To Respond

When FDA determines that a drug or biologic application (i.e., an NDA, ANDA, or BLA) is not approvable, it sends a complete response letter (CRL) to the application sponsor to communicate that the review...

United States Healthcare

AP

Arnold & Porter

1972 Washington Redskins Led Sweep Of Anti-Drug Public Service Campaign

I became a Diversion Investigator with the Drug Enforcement Administration ("DEA") in 1986, but it only recently dawned on me that my relationship with the agency actually began as a ninth grader about 14 years earlier.

United States Healthcare

HP

Hyman, Phelps, & McNamara

Benesch's Dental/DSO Intelligence Monthly Report: October 2025

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Album 9, Track 9: Steady On – Lantern Pharma (Podcast)

United States Healthcare

PL

Polsinelli LLP

The Tests They Are A-Changing: FDA Takes Action On Biosimilars

United States Healthcare

HP

Hyman, Phelps, & McNamara

Prefilled Syringe Presentation Of GSK's SHINGRIX Receives Positive CHMP Opinion

United States Healthcare

GP

Goodwin Procter LLP

Holland & Knight Health Dose: November 4, 2025

United States Healthcare

HK

Holland & Knight

European Bioeconomy Alliance Report Confirms Benefits Of Using First-Generation Biomass For Food, Fuels, And Chemicals In Europe

European Union Healthcare

BC

Bergeson & Campbell

FDA Proposes To Eliminate Comparative Clinical Efficiency Studies For Biosimilars

United States Healthcare

AP

Arnold & Porter

California's New Allergen-Disclosure Law: A Sign Of Things To Come?

United States Healthcare

HP

Hyman, Phelps, & McNamara

Onshoring Drug Manufacturing: Insights From FDA's PreCheck Initiative And Public Meeting

United States Healthcare

HP

Hyman, Phelps, & McNamara

You've Got Mail, And Twice The Time To Respond! Two Device Companies Find Themselves With 30 Business Days To Respond To FDA's Warning Letters

United States Healthcare

HP

Hyman, Phelps, & McNamara

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Healthcare

Health Law Diagnosed: The Summer / Fall 2025 PBM Policy And Legislative Update (Podcast)

In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate David Gilboa for an overview of the Summer / Fall 2025 PBM Policy and Legislative Update...

United States Healthcare

M

Mintz

Immigration Challenges Facing The U.S. Healthcare Workforce

The U.S. healthcare system continues to experience severe workforce shortages, particularly in underserved areas and rural communities.

United States Immigration

Garfinkel Immigration Law Firm

Health Care / Privacy, Cyber & Data Strategy Advisory | HIPAA Security Rule: Still On Track For Finalization

Our Health Care and Privacy, Cyber & Data Strategy groups review the status of the proposed update to the HIPAA Security Rule.

United States Technology

AB

Alston & Bird

Benesch's Dental/DSO Intelligence Monthly Report: October 2025

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Album 9, Track 9: Steady On – Lantern Pharma (Podcast)

United States Healthcare

PL

Polsinelli LLP

The Tests They Are A-Changing: FDA Takes Action On Biosimilars

United States Healthcare

HP

Hyman, Phelps, & McNamara

Holland & Knight Health Dose: November 4, 2025

United States Healthcare

HK

Holland & Knight

California's New Allergen-Disclosure Law: A Sign Of Things To Come?

United States Healthcare

HP

Hyman, Phelps, & McNamara

Onshoring Drug Manufacturing: Insights From FDA's PreCheck Initiative And Public Meeting

United States Healthcare

HP

Hyman, Phelps, & McNamara

See more

Life Sciences, Biotechnology & Nanotechnology

UPC Court Of Appeal Provides Framework For Enforcement By Penalty Payments

The Unified Patent Court (UPC) Court of Appeal has issued a significant decision in Fujifilm v Kodak (UPC_CoA_699/2025)...

United States IP

JA

J A Kemp LLP

Complete Response Letters In Transition: Navigating FDA's Transparency Policy And Manufacturing-Related Actions, And How To Respond

When FDA determines that a drug or biologic application (i.e., an NDA, ANDA, or BLA) is not approvable, it sends a complete response letter (CRL) to the application sponsor to communicate that the review...

United States Healthcare

AP

Arnold & Porter

Benesch's Dental/DSO Intelligence Monthly Report: October 2025

There are several key takeaways from recent PitchBook outlooks and private equity (PE) industry updates that directly apply to dental organizations—particularly DSOs (Dental Service Organizations)....

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Prefilled Syringe Presentation Of GSK's SHINGRIX Receives Positive CHMP Opinion

United States Healthcare

GP

Goodwin Procter LLP

Holland & Knight Health Dose: November 4, 2025

United States Healthcare

HK

Holland & Knight

European Bioeconomy Alliance Report Confirms Benefits Of Using First-Generation Biomass For Food, Fuels, And Chemicals In Europe

European Union Healthcare

BC

Bergeson & Campbell

FDA Proposes To Eliminate Comparative Clinical Efficiency Studies For Biosimilars

United States Healthcare

AP

Arnold & Porter

California's New Allergen-Disclosure Law: A Sign Of Things To Come?

United States Healthcare

HP

Hyman, Phelps, & McNamara

Onshoring Drug Manufacturing: Insights From FDA's PreCheck Initiative And Public Meeting

United States Healthcare

HP

Hyman, Phelps, & McNamara

See more

Food and Drugs Law

Spotlight On Upcoming Oral Arguments – November 2025

The following arguments will be available live to the public, both in-person and through online audio streaming. Access information will be available by 9 AM ET each day...

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Health Law Diagnosed: The Summer / Fall 2025 PBM Policy And Legislative Update (Podcast)

In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate David Gilboa for an overview of the Summer / Fall 2025 PBM Policy and Legislative Update...

United States Healthcare

M

Mintz

Complete Response Letters In Transition: Navigating FDA's Transparency Policy And Manufacturing-Related Actions, And How To Respond

When FDA determines that a drug or biologic application (i.e., an NDA, ANDA, or BLA) is not approvable, it sends a complete response letter (CRL) to the application sponsor to communicate that the review...

United States Healthcare

AP

Arnold & Porter

1972 Washington Redskins Led Sweep Of Anti-Drug Public Service Campaign

United States Healthcare

HP

Hyman, Phelps, & McNamara

Benesch's Dental/DSO Intelligence Monthly Report: October 2025

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

The Tests They Are A-Changing: FDA Takes Action On Biosimilars

United States Healthcare

HP

Hyman, Phelps, & McNamara

Holland & Knight Health Dose: November 4, 2025

United States Healthcare

HK

Holland & Knight

European Bioeconomy Alliance Report Confirms Benefits Of Using First-Generation Biomass For Food, Fuels, And Chemicals In Europe

European Union Healthcare

BC

Bergeson & Campbell

FDA Proposes To Eliminate Comparative Clinical Efficiency Studies For Biosimilars

United States Healthcare

AP

Arnold & Porter

See more

Latest Videos

See more

Ready To Deal: What Healthcare Providers Need To Know Before Raising Capital Or Selling (Video)

SM

Sheppard Mullin Richter & Hampton

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

AM

Alvarez & Marsal

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Inside MedTech Translation Challenges: Ensuring Multilingual Regulatory Compliance

Moringside

Upcoming Events

ATA EDGE 2025 Policy Conference

United States Healthcare

FL

Foley & Lardner

37th Annual Health Law Forum

United States Healthcare

BB

Bass, Berry & Sims

Colorado Life Sciences Summit

United States Healthcare

FH

Foley Hoag LLP

Pharmaceutical EHS Counsel Roundtable

United States Healthcare

BD

Beveridge & Diamond

Global MedTech Showcase By One Six 8 Ventures

United States Healthcare

M

Mintz

Business Breakfast

The Future Of Aging In New York

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Chris DeMeo To Speak At The 2025 Rheumatology Private Practice Alliance Growth Summit

United States Healthcare

SS

Seyfarth Shaw LLP

GC Healthcare Roundtable Discussion - A Fireside Chat With Dr. Susan Monarez, Former CDC Director

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More